跳至主要内容
临床试验/NCT06001034
NCT06001034已完成不适用

A 9-week Program of Supervised Occlusive Aerobic Training in People With Fibromyalgia in a Hospital Setting, and Its Impact on Blood/Plasma Variables, Quality of Life and Functional Autonomy.

José Carlos Rodríguez Bautista2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2022年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
37
试验地点
2
主要终点
Change in Coenzyme Q10 after a 9-week intervention period.

研究概览

简要总结

Occlusive training in people with fibromyalgia

详细描述

Intervention study in people with fibromyalgia with the implementation of a lower body occlusive tool in aerobic exercise. The study aims to descriptively test the impact on quality of life and functional autonomy of occlusive training in a controlled and individualized way in two groups: group 1 aerobic exercise with use of occlusive tool and group 2, aerobic exercise without occlusive tool in a period of 9 weeks twice a week.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A patient meets diagnostic criteria for fibromyalgia if the following three conditions are present: (American Rheumatology Association). Wolfe et al., (2010).
  • o 1) Widespread Pain Index (WPI) ≥ 7 and Symptom Severity Score (SS Score) ≥ 5 or WPI 3-6 and SS ≥
  • Symptoms have been present, at a similar level, during the last three months.
  • The patient has no other pathology that could explain the pain.
  • Recent negative COVID-19 test.

排除标准

  • Other associated pathologies that may hinder the development of the research.
  • Mobility limitations.
  • Injuries that add to those of the disease itself and hinder mobility.
  • No medical evaluation of the diagnosis of the disease.
  • Negative results in the inclusion tests.
  • Cardiac pathologies.
  • Blood pressure higher than 130-90 mmHg.
  • No COVID-19 test.

结局指标

主要结局

Change in Coenzyme Q10 after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

Coenzyme Q10

Change in disease impact questionnaire MFI-20 after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

MFI-20; (0-60) no fatigue. (60-70), fatigue, lighter or more severe, depending on the depending on the rating closer to 60 or 70 points. (more than 70 points), severe fatigue.

Change in low density lipoproteins after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

LDL

Change in triglycerides after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

TG

Change in distance traveled after a 9-week intervention period.

时间窗: From week 1 to week 9 of the intervention period.

Pedometer registration. Immediately after each session from week 1 to 9 of the intervention period. With a total of 18 recordings over the 9 weeks of the intervention period.

Change in total antioxidants after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

TAS

Change in disease impact questionnaire WPI after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

WPI; score between (0-19). The higher the score, the greater the impact of the disease.

Change in disease impact questionnaire SSscore after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

SS score; score between (0-3) in the first half. Score between (0-40); between 1-10 (1 point), between 11-24 (2 points), more than 25 (3 points) in the second half. The higher the score, the greater the impact of the disease.

Change in disease impact questionnaire FIQ after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

FIQ; score between (0-100). The higher the score, the greater the impact of the disease

Change in high density lipoproteins after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

HDL

Changes in urea after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

Urea

Changes in creatinine after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

Creatinine

Change in total cholesterol lipoproteins after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

CHOL

Change in malondialdehyde after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

MDA (malondialdehyde)

Change in gamma-glutamyl transferase after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

GGT

Change in glutamic-pyruvic transaminase after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

GPT

Change in alkaline phosphatase after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

ALP

Change in glutamic oxaloacetic acid transaminase after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period).

GOT

Change in visual pain scale VAS over a 9-week intervention period.

时间窗: From week 1 to week 9 of the intervention period.

Visual pain scale (1-10). 1 being lighter and 10 being more severe. Visual pain scale recording. Before and immediately after each session from week 1 to week 9 of the intervention period. With a total of 36 recordings during the 9 weeks of the intervention period.

Change in perceived exertion scale BORG over a 9-week intervention period.

时间窗: From week 1 to week 9 of the intervention period.

Perceived exertion scale. (1-10). 1 being lighter and 10 being more severe. Perceived exertion scale recording. Before and immediately after each session from week 1 to week 9 of the intervention period. With a total of 36 recordings during the 9 weeks of the intervention period.

Change in funcional test after a 9-week intervention period.

时间窗: Pre (before the start of the 9-week intervention period). Post (immediately after the 9-week intervention period)

6-minute walking test

次要结局

未报告次要终点

研究者

发起方
José Carlos Rodríguez Bautista
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

José Carlos Rodríguez Bautista

PhD currently Sport Sciences in Physical Activity, Health and Quality of Life

Universidad Pablo de Olavide

研究点 (2)

Loading locations...

相似试验